SHORT MINI FUTURE - PFIZER INC | Market Closed - Swiss Exchange 11:20:00 2024-07-12 am EDT | ||
| 0.78 CHF | -4.88% |
|
| Current month | -10.34% | ||
| 1 month | -10.34% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 0.78 | -4.88% |
| 24-07-11 | 0.82 | -5.75% |
| 24-07-10 | 0.87 | -5.43% |
| 24-07-09 | 0.92 | +5.75% |
| 24-07-04 | 0.87 | -2.25% |
Delayed Quote Swiss Exchange
Last update July 12, 2024 at 11:20 am EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | PFIZER, INC. |
| Issuer | Bank Julius Bär |
| LPFCJB | |
| ISIN | CH1286513820 |
| Date issued | 2023-09-12 |
| Strike | 37.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.355 CHF |
| Emission volume | N/A |
| Settlement | cash |
| Currency | CHF |
Technical Indicators
| Highest since issue | 1.15 CHF |
|---|---|
| Lowest since issue | 0.38 CHF |
| Spread | 0.01 CHF |
| Spread % | 1.28% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.92
USD
Average target price
32.1
USD
Spread / Average Target
+10.99%
- Stock Market
- Certificates
- LPFCJB Certificat
